Virtual Medicinal Product (VMP) - Dolutegravir 5mg / Abacavir 60mg / Lamivudine 30mg dispersible tablets sugar free

Navigation

Name Details

Name Start Date End Date
Name Current Name Dolutegravir 5mg / Abacavir 60mg / Lamivudine 30mg dispersible tablets sugar free Start Date 02-04-2025 End Date
Previous Name Previous Name Generic Triumeq 5mg/60mg/30mg dispersible tablets sugar free Start Date 18-12-2023 End Date 01-04-2025
Abbreviated Name Abbreviated Name Dolutegravir 5mg/Abacavir 60mg/Lamivudine 30mg disp tab SF Start Date 02-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Dispersible tablet
Ontology Form/Route
suspension.oral
Free From
Sugar-free
Name Basis
Other

Codes

ATC Code
J05AR13
BNF Codes
  • BNF code 05030100
SNOMED Codes
Code Start Date End Date
42534411000001107 18-12-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Abacavir sulfate Based on Base Substance Abacavir 60 mg
Dolutegravir sodium Based on Base Substance Dolutegravir 5 mg
Lamivudine Based on Ingredient Substance 30 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
90 tablet